0001615192-19-000008.txt : 20190611 0001615192-19-000008.hdr.sgml : 20190611 20190611162400 ACCESSION NUMBER: 0001615192-19-000008 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190610 FILED AS OF DATE: 20190611 DATE AS OF CHANGE: 20190611 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McGrody Kevin J CENTRAL INDEX KEY: 0001615192 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34634 FILM NUMBER: 19891271 MAIL ADDRESS: STREET 1: ICU MEDICAL, INC. STREET 2: 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92673 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ICU MEDICAL INC/DE CENTRAL INDEX KEY: 0000883984 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330022692 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92763-6212 BUSINESS PHONE: 949-366-2183 MAIL ADDRESS: STREET 1: 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92763-6212 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2019-06-10 0 0000883984 ICU MEDICAL INC/DE ICUI 0001615192 McGrody Kevin J 951 CALLE AMANECER SAN CLEMENTE CA 92673 0 1 0 0 Controller Common Stock 2019-06-10 4 X 0 3805 58.79 A 7574 D Common Stock 2019-06-10 4 X 0 438 61.76 A 8012 D Common Stock 2019-06-10 4 S 0 3019 231.37 D 4993 D Common Stock 2019-06-10 4 S 0 82 231.95 D 4911 D Common Stock 2019-06-10 4 S 0 4243 231.89 D 668 D Non-Qualified Stock Option (right to buy) 58.79 2019-06-10 4 X 0 3805 58.79 D 2024-02-24 Common Stock 3805 0 D Non-Qualified Stock Option (right to buy) 61.76 2019-06-10 4 X 0 438 61.76 D 2023-02-06 Common Stock 438 0 D These securities are vested Restricted Stock Units. The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $231.23 to $231.75, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Shares were previously acquired through the Registrant's Employee Stock Purchase Plan. All shares sold were sold at the exact price disclosed. Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years. By: Alejandro Parras, Attorney-In-Fact For: Kevin J. McGrody 2019-06-11